Business
Omada Health Joins Lilly Employer Connect, Expanding Its Access Pathways for GLP-1 Care as Patients Seek More Lifestyle Support
Survey of more than 3,000 GLP‑1 patients reveals care gaps and rising out‑of‑pocket costs, underscoring employers’ need to pair flexible GLP‑1 access with ongoing lifestyle supportSAN FRANCISCO, May 07, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA) announced it will serve as an independent program administrator in Eli Lilly and Company’s Employer Connect program. Omada will offer its GLP‑1 Care Track, including clinical evaluation, prescribing, and ongoing medication management, to employ
About this update from Omada Health, Inc.
[{"type":"image","alt":"Omada Health, Inc.","displaySize":"","headline":null,"caption":"Omada Health, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":70,"url":"https://media.zenfs.com/en/globenewswire.com/c16cfad848d897c3a884329d0ddf5bfe"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/reaHzLGW7kAjLdXL75ImlQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTk4/https://media.zenfs.com/en/globenewswire.com/c16cfad848d897c3a884329d0ddf5bfe","width":300,"height":70}},"lazy":false},{"type":"text","content":"Survey of more than 3,000 GLP‑1 patients reveals care gaps and rising out‑of‑pocket costs, underscoring employers’ need to pair flexible GLP‑1 access with ongoing lifestyle support","length":180,"tagName":"p"},{"type":"text","content":"SAN FRANCISCO, May 07, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA) announced it will serve as an independent program administrator in Eli Lilly and Company’s Employer Connect program. Omada will offer its GLP‑1 Care Track, including clinical evaluation, prescribing, and ongoing medication management, to employers. This adds a new direct‑to‑employer channel alongside Omada’s existing pharmacy benefit manager and cash‑pay pathways to make it easier for employers to offer weight loss medications with coordinated lifestyle support.","length":542,"tagName":"p"},{"type":"text","content":"Integrating with Lilly’s Employer Connect allows Omada to provide another option with transparent net cost for Zepbound® and enables defined contribution levels from employers, creating a predictable cost structure for obesity medications. Omada’s other offerings include prescribing, guided medication care, and ongoing lifestyle support before, during, and after GLP-1 therapy, helping members achieve lasting results while employers utilize a single, coordinated cardiometabolic program.","length":490,"tagName":"p"},{"type":"text","content":"Demand for anti-obesity medicines is growing and putting pressure on employer budgets, leading to limited and inconsistent coverage for GLP‑1s for weight loss.1 With Lilly’s Employer Connect program, Omada’s GLP‑1 Flex Care cash-pay option, and existing pharmacy benefit manager pathways, employers now have multiple ways to adapt coverage design to pair medications with behavioral support through Omada’s program.","length":415,"tagName":"p"},{"type":"text","content":"“Empl...